Invesco
MBIO icon

Invesco’s Mustang Bio MBIO Stock Holding History

Invesco’s Portfolio MBIO Stock Details MBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-29
Closed -$22K – 4100
2022
Q1 		$22K Hold
29
– – ﹤0.01% 3987
2021
Q4 		$36K Hold
29
– – ﹤0.01% 4001
2021
Q3 		$59K Sell
29
-1
-3% -$2.15K ﹤0.01% 3992
2021
Q2 		$75K Buy
30
+1
+3% +$2.45K ﹤0.01% 3926
2021
Q1 		$72K Buy
29
+2
+7% +$5.95K ﹤0.01% 3799
2020
Q4 		$77K Buy
+27
New +$64.5K ﹤0.01% 3677

Other funds holding MBIO

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
TI
Telemetry Investments New York $63.3M AUM 0.06% 1-Year Est. Return

Invesco's MBIO Position: Q2 2022 in Review

Invesco sold out of Mustang Bio (MBIO) in Q2 2022, closing a stake of 29 shares — an estimated $22K sold.

Invesco first reported a position in MBIO in Q4 2020 and held it in 6 quarters. The position peaked at $77K in Q4 2020. 71 funds tracked by Wall St. Rank hold MBIO as of Q2 2022.

  • Invesco reported no remaining Mustang Bio position as of Q2 2022 after selling out during the quarter.
  • Invesco sold 29 Mustang Bio shares in Q2 2022, an estimated $22K.
  • Invesco first reported a position in Mustang Bio in Q4 2020 and held it in 6 quarters.
  • Invesco's Mustang Bio position peaked at $77K in Q4 2020.
  • 71 funds tracked by Wall St. Rank held Mustang Bio as of Q2 2022.

Based on Invesco's 13F filing for Q2 2022, filed 15 Aug 2022.